DXCM vs. VRSK

Last updated Apr 2, 2026

Compare and contrast key facts about DexCom, Inc. (DXCM) and Verisk Analytics, Inc. (VRSK).

Performance

DXCM vs. VRSK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in DexCom, Inc. (DXCM) and Verisk Analytics, Inc. (VRSK). The values are adjusted to include any dividend payments, if applicable.

DXCM vs. VRSK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
DXCM DexCom, Inc.	-6.03%	-14.66%	-37.33%	9.58%	-15.64%	45.23%	69.02%	82.59%	108.75%	-3.87%
VRSK Verisk Analytics, Inc.	-17.76%	-18.23%	16.00%	36.24%	-22.33%	10.85%	39.89%	37.92%	13.58%	18.27%

Fundamentals

Market Cap DXCM : $24.88B VRSK : $25.53B
EPS DXCM : $2.07 VRSK : $6.50
PE Ratio DXCM : 30.19 VRSK : 28.24
PEG Ratio DXCM : 0.72 VRSK : 1.59
PS Ratio DXCM : 5.42 VRSK : 33.39
Total Revenue (TTM) DXCM : $4.66B VRSK : $768.30M
Gross Profit (TTM) DXCM : $2.80B VRSK : $538.80M
EBITDA (TTM) DXCM : $1.34B VRSK : $1.42B

Returns By Period

In the year-to-date period, DXCM achieves a -6.03% return, which is significantly higher than VRSK's -17.76% return. Over the past 10 years, DXCM has outperformed VRSK with an annualized return of 13.94%, while VRSK has yielded a comparatively lower 9.15% annualized return.

DXCM

• 1D: -0.68%
• 1M: -15.46%
• YTD: -6.03%
• 6M: -5.61%
• 1Y: -7.35%
• 3Y*: -18.73%
• 5Y*: -7.35%
• 10Y*: 13.94%

VRSK

• 1D: -3.29%
• 1M: -14.35%
• YTD: -17.76%
• 6M: -26.13%
• 1Y: -38.07%
• 3Y*: -0.83%
• 5Y*: 1.07%
• 10Y*: 9.15%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

DXCM vs. VRSK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DXCM

DXCM Risk / Return Rank: 32
DXCM Sharpe Ratio Rank: 32
DXCM Sortino Ratio Rank: 30
DXCM Omega Ratio Rank: 30
DXCM Calmar Ratio Rank: 34
DXCM Martin Ratio Rank: 33

VRSK

VRSK Risk / Return Rank: 6
VRSK Sharpe Ratio Rank: 1
VRSK Sortino Ratio Rank: 3
VRSK Omega Ratio Rank: 3
VRSK Calmar Ratio Rank: 12
VRSK Martin Ratio Rank: 8

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DXCM vs. VRSK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for DexCom, Inc. (DXCM) and Verisk Analytics, Inc. (VRSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DXCM	VRSK	Difference
Sharpe ratio Return per unit of total volatility	-0.17	-1.29	+1.12
Sortino ratio Return per unit of downside risk	0.06	-1.78	+1.84
Omega ratio Gain probability vs. loss probability	1.01	0.76	+0.25
Calmar ratio Return relative to maximum drawdown	-0.22	-0.81	+0.58
Martin ratio Return relative to average drawdown	-0.45	-1.51	+1.07
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DXCM vs. VRSK - Sharpe Ratio Comparison

The current DXCM Sharpe Ratio is -0.17, which is higher than the VRSK Sharpe Ratio of -1.29. The chart below compares the historical Sharpe Ratios of DXCM and VRSK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	DXCM	VRSK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.17	-1.29	+1.12
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.16	0.05	-0.20
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.29	0.39	-0.10
Sharpe Ratio (All Time) Calculated using the full available price history	0.29	0.56	-0.27

Correlation

The correlation between DXCM and VRSK is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

DXCM vs. VRSK - Dividend Comparison

DXCM has not paid dividends to shareholders, while VRSK's dividend yield for the trailing twelve months is around 1.01%.

	TTM	2025	2024	2023	2022	2021	2020	2019
DXCM DexCom, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
VRSK Verisk Analytics, Inc.	1.01%	0.80%	0.57%	0.57%	0.70%	0.51%	0.52%	0.67%

Drawdowns

DXCM vs. VRSK - Drawdown Comparison

The maximum DXCM drawdown since its inception was -94.61%, which is greater than VRSK's maximum drawdown of -46.98%. Use the drawdown chart below to compare losses from any high point for DXCM and VRSK.

Drawdown Indicators

	DXCM	VRSK	Difference
Max Drawdown Largest peak-to-trough decline	-94.61%	-46.98%	-47.63%
Max Drawdown (1Y) Largest decline over 1 year	-38.75%	-46.98%	+8.23%
Max Drawdown (5Y) Largest decline over 5 years	-66.32%	-46.98%	-19.34%
Max Drawdown (10Y) Largest decline over 10 years	-66.32%	-46.98%	-19.34%
Current Drawdown Current decline from peak	-61.69%	-42.45%	-19.24%
Average Drawdown Average peak-to-trough decline	-35.79%	-6.79%	-29.00%
Ulcer Index Depth and duration of drawdowns from previous peaks	19.36%	25.01%	-5.65%

Volatility

DXCM vs. VRSK - Volatility Comparison

DexCom, Inc. (DXCM) and Verisk Analytics, Inc. (VRSK) have volatilities of 9.22% and 9.42%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DXCM	VRSK	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.22%	9.42%	-0.20%
Volatility (6M) Calculated over the trailing 6-month period	27.60%	24.77%	+2.83%
Volatility (1Y) Calculated over the trailing 1-year period	43.67%	29.61%	+14.06%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	46.76%	23.67%	+23.09%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	48.30%	23.53%	+24.77%

Financials

DXCM vs. VRSK - Profitability Comparison

The chart below illustrates the profitability comparison between DexCom, Inc. and Verisk Analytics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

DXCM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, DexCom, Inc. reported a gross profit of 792.70M and revenue of 1.26B. Therefore, the gross margin over that period was 62.9%.

VRSK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Verisk Analytics, Inc. reported a gross profit of -1.07B and revenue of -1.53B. Therefore, the gross margin over that period was 69.8%.

DXCM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, DexCom, Inc. reported an operating income of 323.00M and revenue of 1.26B, resulting in an operating margin of 25.6%.

VRSK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Verisk Analytics, Inc. reported an operating income of -684.40M and revenue of -1.53B, resulting in an operating margin of 44.9%.

DXCM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, DexCom, Inc. reported a net income of 267.30M and revenue of 1.26B, resulting in a net margin of 21.2%.

VRSK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Verisk Analytics, Inc. reported a net income of 197.20M and revenue of -1.53B, resulting in a net margin of -12.9%.